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Abstract
Exhaled breath condensate (EBC) and associated exhaled breath aerosols (EBA) are valuable
non-invasive biologicalmedia used for the quantification of biomarkers. EBC contains exhaled
water vapor, soluble gas-phase (polar) organic compounds, ionic species, plus other species
including semi- and non-volatile organic compounds, proteins, cell fragments, DNA, dissolved
inorganic compounds, ions, andmicrobiota (bacteria and viruses) dissolved in the co-collected
EBA. EBC is collected from subjects who breathe ‘normally’ through a chilled tube assembly for
approximately 10min and is then harvested into small vials for analysis. Aerosol filters without the
chilled tube assembly are also used to separately collect EBA. Unlike typical gas-phase breath
samples used for environmental and clinical applications, the constituents of EBC and EBA are not
easily characterized by total volume or carbon dioxide (CO2) concentration, because the gas-phase
is vented. Furthermore, EBC and associated EBA are greatly affected by breathing protocol, more
specifically, depth of inhalation and expelled breath velocity.We have tested a new instrument
developed by Loccioni GruppaHumancare (Ancona, Italy) for implementation of EBC collection
fromhuman subjects to assess EBC collection parameters. The instrument is the first EBC collection
device that provides instantaneous visual feedback to the subjects to control breathing patterns. In
this report we describe the operation of the instrument, and present an overview of performance
and analytical applications.
1. Introduction
There has been significant interest in the ability of
breath analysis to identify target compounds and
trends in the constituents of exhaled breath as a tool
for diagnosing and monitoring medical conditions,
and for discovering a growing number of biomarkers
thatmight indicate recent environmental exposures or
preclinical disease state [1–3]. In fact, there is ongoing
research regarding the mixtures of exogenous, endo-
genous, and microbiome contributions to breath
samples, and for volatiles emissions in other biological
media, for deducing specific retrospective or prospec-
tive effects [4–7].
Exhaled breath contains measurable levels of vola-
tile organic compounds (VOCs), semi-volatile organic
compounds (SVOCs), proteins, lipids, DNA and
microbiota such as bacteria and viruses. The central
goal of exhaled breath analysis is to non-invasively
gain insight into previous occupational or environ-
mental exposures and/or the presence or status of a
medical condition or infectious state [6, 8, 9]. Exhaled
breath analysis is less invasive, more easily repeatable
and less expensive than alternative invasive tests [10].
There are various methods for collecting and analyz-
ing exhaled breath, depending on the constituent of
interest. If the target of interest is a protein, lipid,
SVOC, or microbiota, collection of exhaled breath
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condensate (EBC) is considered the ideal approach
[11–14]. While there is significant interest in the col-
lection and analysis of biomarkers in EBC for disease
detection and monitoring, there are currently sub-
stantial issues with the collection and analysis of
breath, in general, and in EBC specifically with respect
to inter-subject and intra-subject variability and a lack
of standardization [15, 16] until very recent recom-
mendations [28]. Concentration of biomarkers as well
as total sample volume in EBC can vary significantly
depending on subject’s health, profession, diet, geno-
type, age, gender, and recent exposure to exogenous
chemicals [10]. In addition, a subject’s respiratory rate,
exhaled breath velocity, and volume of each exhaled
breath has been shown to significantly affect EBC
volume [17–19]. Currently there is minimal standar-
dization of methods or techniques to collect EBC,
resulting in substantial difficulty comparing results
within and across studies [15]. Given that the applica-
tions of examining EBC biomarkers are extremely
broad, the complete standardization of EBC collection
protocols is unrealistic [12, 15]. However, an instru-
ment that assists in the control of a subject’s breathing
rate and exhalation volume may be useful in reducing
inter-subject and intra-subject variability within a spe-
cific study and for certain biomarkers.
Herein, we report the efficacy of one such device,
the Loccioni instrument, which was adapted from a
prototype clinical instrument used previously for gas-
phase health studies [20]. This instrument provides
real-time feedback and breath cues to the subject to
regulate breathing frequency and tidal volume. In this
study, we compare consistency of EBC volume and
pH of samples collected by controlled ‘paced’ breath-
ing using a new instrument with verbal and audio
prompts to samples collected by uncontrolled free
breathing. ‘Paced’ breathing, with the goal of produ-
cing a fairly reproducible tidal volume and frequency,
typically involves audio, visual, and/or vibratory
prompts for the subject; we use this interchangeable
with controlled breathing for the purposes of this
report. This work is in two parts; the first is based on a
collection of various samples drawn from exploratory
sample collections from research into environmental
exposures, and the second part is a detailed long-
itudinal comparison of specific parameters between
groups. The primary goal is to assess if the controlled
breathing technique presents any advantage to EBC
sample standardization, such as decreased variability.
We utilized two collection durations—a short (6 min)
collection when a minimal amount of time to provide
a relatively small EBC volume is required, and a longer
(10 min) one for potential studies needing a larger
amount of EBC volume.
2.Methods
2.1. Instrument
The instrument, provided by Loccioni Gruppa
HumanCare (Ancona Italy), instantaneouslymeasures
CO2 concentration, volume of each breath and total
volume exhaled during sampling. While CO2 concen-
tration was not directly recorded for our research, it
may be useful for determining where in the lung the
exhaled breath originated or to confirm complete
exhalation [21, 22]. In addition, the Loccioni instru-
ment also has an interactive screen that visually guides
the subject’s volume of air inhaled and exhaled and
also acts as a audio metronome in order to prompt a
subject when to reverse direction of breathing
(figure 1). The respiratory rate for controlled breathing
can be programmed from 6 to 16 breaths min−1, and
individual breath volume programmed from 100 to
1500 ml/breath, which may allow for targeting of air
from a specific region within the lung or breathing
pattern. Total exhaled volume is also provided. There
is no valve to allow collection of specific exhaled breath
fractions.
Figure 1. Loccioni instrument interactive screen. The interactive screen guides the subject’s breathing patternwith instantaneous tidal
volumemeasurements and an auditorymetronome. The interactive screen allows the researcher to adjust breathing frequency and
also provides the researcher with an instantaneous endtidal CO2measurement and total volume exhaled.
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2.2.Human subjects
EBC biological specimens were collected from four
adult volunteers during the methods development
phase of studies conducted under the Institutional
Review Board (IRB) auspices of IRB Study#: 09-1344
and IRB Study# 99-283,University ofNorthCarolina,
Chapel Hill NC. Additional longitudinal evaluations
were conducted ad hoc under an exemption to the
common rule for biological specimens.
2.3. EBC collectionmethod
EBC samples were collected using R-tubes (Respira-
tory Research Inc. Austin, TX, USA). The R-tube was
placed inside an aluminum sleeve, which was sur-
rounded by dry ice within an 8 cm diameter co-axial
container (‘condensation chamber’). A Respirguard
303 filter (Vital Signs, SanDiego, CA)was placed at the
intake of the R-tube in order to prevent the introduc-
tion of microbes into the Loccioni Instrument
(figure 2). A plastic fitting containing the CO2 and air
volume sensor was installed between the Respirguard
303 filter and the R-tube (figure 2). The sensor was
installed on both the spontaneous and controlled
sampling methods for consistency and to measure the
final total air volume exhaled. The metronome and
individual breath volume feedback mechanisms were
not used for the spontaneous breathing samples.
Subjects remained seated while breathing through
the filter without nose clips. Upon completion of sam-
ple collection, the R-tube was capped and condensate
thawed at room temperature. Once thawed, the con-
densate was consolidated using the internal O-ring
squeegee in collaboration with the R-tube plunger.
The volume of each sample wasmeasured and samples
transferred to a 2 ml polypropylene centrifuge tube for
storage in−20 °C freezer until pH analysis.
For this initial study, we collected 114 samples. 102
of the 114 samples were collected in sets of three.
Between samples within the same set, an approximately
7min gap was necessary to prepare for the following
sample.Of the 114 samples, 57 samples had a 6min col-
lection time, while the remaining 57 samples were col-
lected over a 10min sample time. Sixty-three of the 114
samples were collected using the Loccioni instrument
to control breathing rate at 10 breaths perminute and a
breath volume of 1000ml of air per breath. This was
defined as controlled breathing. Of the 63 controlled
samples, 30 were collected for 6 min, while the remain-
ing 33 samples were collected over a 10min sampling
period. The remaining 51 samples did not use the Loc-
cioni instrument to control breathing rate and volume.
Instead, the subject was instructed to breathe at a reg-
ular frequency and tidal volume.Of the 51 spontaneous
samples, 27 were collected for 6 min, while the remain-
ing 24were collected over a 10min sampling period.
2.4. pH analysis
pH was measured for all EBC samples with sufficient
volume. A minimum of approximately 1.3 ml of EBC
was required to accurately cover the pHmeter electrode
bulb. Few individual EBC samples had a volume of
1.3 ml ormore, so EBC samples from each triplicate set
(collected within 45min) were blended together to
provide sufficient volume for a single pHmeasurement.
pH was analyzed using a Thermo Scientific Ross Ultra
pH Electrode, connected to Thermo Scientific Orion
Star A211 pHmeter (Waltham,MA). Thermo Scientific
Orion Pure Water Low Ionic Strength pH buffers were
selected for pH meter calibration. Argon was bubbled
into each pH sample for 10min, then the pH electrode
was immediately placed into the sample. pH was
recorded once the value stabilized.
2.5. Statistical analysis
Statistical analyses and tests were performed using
Prism 7 software (GraphPad Software, SnDiegoCA).
Figure 2.EBC collection system. The principal components of the collection system include the R-tube, the condensation chamber,
the Respirguard 303 filter and theCO2 and air volume sensor. The condensation chamber isfilledwith dry ice, which cools the R-tube
to−78 °C. ARespirguard 303filter is in place to prevent accumulation ofmicrobes within the Loccioni instrument. TheCO2 and air
volume sensor are located between the R-tube and the Respirguard 303 filter.
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3. Results
3.1. EBC volume
Reducing variability in EBC sample volume and
biomarker concentration is a key goal for the standar-
dization of breath analysis. To determine the efficacy
of the Loccioni instrument in reducing variability, the
EBC sample volume collected over 6 and 10 min using
the Loccioni instrument was compared to the 6 and
10 min samples that were collected through sponta-
neous breathing. The variability of EBC volume using
the Loccioni instrument was notably reduced in
comparison to the spontaneous breathing EBC sam-
ples, regardless of collection time (figure 3). For
samples collected for 6 min using the spontaneous
breathing method, the mean value was 0.91 ml, with a
range of 0.72–1.13 ml and a coefficient of variation of
0.124. In contrast, for samples collected using the
controlled breathing method, the mean value was
0.71 ml, with a range of 0.52–0.82 ml and a coefficient
of variation of 0.100. For samples collected for 10 min
using the spontaneous breathing method, the mean
value was 1.62 ml, with a range of 1.10–2.19 ml, and a
coefficient of variation of 0.159, compared to themean
value being 1.20 ml, with a range of 1.01–1.63 ml, and
a coefficient of variation of 0.103 using the controlled
breathingmethod. The larger volumewith the sponta-
neous breathing pattern likely derives from larger and
more frequent breaths especially hyperventilation at
the initiation of collection.
Intra-subject variability in EBC volume and bio-
marker concentration is inherent in EBC samples col-
lected on different days. Therefore, to compare intra-
subject variability between spontaneous and con-
trolled breathing in samples collected in rapid succes-
sion, the majority of EBC samples were collected in
sets of three using an identical sampling method and
collection time. To determine whether the Loccioni
instrument reduced same-day variability, EBC volume
from each sample was graphed by sample set. The
variability between 10 min samples collected in rapid
succession using the Loccioni instrument was notably
smaller in comparison to the 10 min samples collected
in rapid succession using the spontaneous breathing
method (figure 4). The largest volume difference
between samples collected in rapid succession from
the same subject for spontaneous breathing and con-
trolled breathing is approximately 0.6 ml and 0.2 ml,
respectively. In addition, variability in sample sets
collected on different days was also markedly reduced
in samples collected using the controlled breathing
method.
3.2. pH analysis
pH of EBC samples is an easilymeasured biomarker to
monitor respiratory acidification, which is associated
with numerous respiratory illnesses [23]. Most of the
EBC samples (31 of 37) had a pH value considered
within the range of normal healthy individuals
(7.08±0.69) [24] (figures 5(A) and (B)). For the
10 min EBC samples, one sample from a subject was
slightly below the pH range found in nominally
healthy individuals (pH=6.12), and two samples
collected from the same subject, approximately
20 min apart, had pHvalues of 4–5, far below the range
of healthy individuals. No asthma-related symptoms
were reported on the day of sample collection but the
subject reported a Staphylococcus aureus infection and
had just begun treatment using antibiotics the day
before. Previous studies have linked bacterial infec-
tions with increased levels of nitric oxide, which may
Figure 3.Comparison of EBC volume by collection time andmethodwithmean and 95% confidence interval displayed. A reduction
in variability between the spontaneous and controlled samplingmethods is evident. (A)Acomparison of volume of 6 min
spontaneous (N=26) samples collected from a single subject, and controlled (N=29) samples collected from two subjects. (B)A
comparison of volume of 10 min spontaneous (N=24) samples collected from three subjects, and controlled (N=33) samples
collected from four subjects. (Each shape reflects a data point from a specific subject.) *There was a statistically significant difference
between controlled and spontaneous breathing patterns at each collection time; p<0.01 (oneway ANOVAwith SidakMultiple
Comparison Test).
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be associated with decreased EBC pH, thus potentially
explaining anomalous pH readings in the two sets of
samples [25, 26]. A Grubbs’ outlier test identified
pH values of 4.9 and 6.12 as a significant outlier in the
6 and 10 min collections with spontaneous breathing,
respectively. With the outlier removed, the mean
pH of the samples using the spontaneous breathing
method for 6 min was 8.29, with a range of 7.8–8.62.
With the outlier removed, the mean pH of sample sets
using the spontaneous breathing method for 10 min
was 8.39, with a range of 7.93–8.66.
4.Discussion
We have illustrated the implementation of a novel
method of controlled cued breathing using a Loccioni
instrument for standardization of EBC. Results from
this instrument evaluation indicated a reduction of
both intra-day and inter-day variability of EBCvolume
with the instrument use. EBC pH results were fairly
consistent across samples from same subjects, regard-
less of collectionmethod and time, which is important
for the application of the R-tube for assaying asthma
status. Additionally, EBC recovery volume and varia-
bility over multiple time points were quantified and
compared, allowing for determination of ideal collec-
tion time for subsequent EBC studies. To determine
an optimal collection time, it is necessary to determine
the ideal collection volume, which is partially depen-
dent on the number and assay types chosen. If
planning to measure cytokine concentrations and pH,
while reserving a sufficient volume for replicate or
follow-up assays, we estimated a sample volume of at
least 0.8 ml would be necessary. The majority (27/29)
samples collected for 6 min using the controlled
method had a final volume of 0.8 ml or less but only 4
of 26 measured samples using the spontaneous
method had a final volume of0.8 ml. However, due
to the reduced variability using the controlledmethod,
the 6 min spontaneous sampling technique was con-
sidered inferior to both the 6 and 10 min controlled
collection method if low volume reproducibility is the
criterion or less volume is needed. These findings with
controlled breathing were obtained without knowl-
edge of the variability in TV and freq for each
Figure 4.Variability of EBC volume by sample set. Variability within sample sets using controlled EBC collectionmethod is
significantly reduced in comparison to spontaneous breathingmethod. (A)EBCvolume collected using spontaneous breathing
method for 10 min.Minimal horizontal linearity is indicative of significant variability in intra-day samples (N=7), collected from a
single subject over approximately 2months. (B)EBC volume collected using controlled breathingmethod for 10 min. Relative
horizontal linearity of each set indicates reduced variability using Loccioni instrument (N = 8), collected from two subjects over
approximately 2months.
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collection, though the total volume was near the target
(100 l), which could be improved with software
reprogramming.
A potential benefit of the 10 min collection time is
the decrease in variability in volume or biomarker
levels relative to spontaneous breathing due to hyper-
ventilation by the subject, which typically can occur
when the subject first expires into the R-tube mouth-
piece and Respirguard 303 filter. It is not clear what
role hyperventilation plays in the recovery of EBC or
concentration of cytokines. While hyperventilation
reduces the pH of blood, previous studies have found
no link between hyperventilation and changes in
EBCpH [27].
Our results indicated that there is less range of EBC
volume in the 6 min samples than in corresponding
10 min samples, regardless of method of collection,
but that the variability expressed as COV were similar
for both the 6 and 10 min collections. This is reason-
able, since there is less time for the sample volume to
diverge. However a smaller EBC volume is collected
over the 6 min. While there was less variability of EBC
volume when using the controlledmethod, this differ-
ence may be more pronounced if the sample subject
size is expanded further. Additionally, early in the
study, the subjects’ spontaneous respiratory rate was
markedly different than the programmed controlled
respiratory rate of 10 breaths per minute. In later sam-
ple collections, the subjects’ spontaneous respiratory
rate was noted to be considerably closer to the con-
trolled breathing rate of 10 breaths per minute, possi-
bly attributable to acclimation to the controlled
breathing rate. Further examination of what different
breathing patterns, e.g. panting, breath holding,
would have on the measured endpoints is needed.
Additional subjects would allow testing of how gen-
eralizable the findings described herein are to the gen-
eral population. Because the general population has a
wider range of lung volumes, the utility of using con-
trolled breathing patterns of similar frequency and
volumes may not be optimal to minimize variability.
Adjustment to a more appropriate volume based on,
e.g. lung volume capacity, may prove to be a better
method to collect samples with minimal variability.
Within the whole population, consideration of the fre-
quency and volume of the controlled breathing pat-
tern should be given to individuals with lung disease as
well, possibly to document changes towards normal
values due to therapies. While not examined in this
report, the total exhaled volume is reported on the
Loccioni instrument so that volume of EBC can be
compared with the breath volume, as per recent
recommendations by a European Respiratory task-
force on exhaled breath collection [28].
5. Conclusions
A controlled breathing pattern using visual and audio
clues to set inhalation and exhalation volumes and
frequency was shown to have decreased variability in
EBC volume compared to spontaneous breathing by
an individual. This decrease in variability using the
controlled breathing was observed with EBC collected
for both 6 and 10 min.
With the controlled breathing pattern, a smaller
EBC volumewas collected at both collection durations
Figure 5.Comparison of pHof EBCby collection time andmethodwithmean and standard error displayed. No variability in
pHbetween sampling collectionmethod and collection timewas observed. (A)A comparison of pHof 6 min spontaneous (N=9)
samples collected from a single subject, and controlled (N=5) samples collected from two subjects. All pH values are derived from
triplicate pooled EBC samples. The pHof three samples are noticeably lower than themean pHof their respective sample group. (B)A
comparison of pHof 10 min spontaneous (N=10) samples collected from three subjects and controlled breathing (N=13) samples
collected from four subjects. For the spontaneous values, sevenwere pooled from triplicate samples, and threewere individual samples
with an adequate volume tomeasure the pH; for the controlled breathing pH values, ninewere pooled from triplicate samples, three
were individual samples, and onewas pooled fromduplicates. The pHof two sets of samples from the same subject are noticeably
lower than themean of the pHof their respective sample collectionmethod. (Each shape reflects a data point from a specific subject.)
Two-way ANOVAperformed comparing samplingmethod and collection duration.
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examined. The collection time may be critical for pro-
curing adequate volume for subsequent analyses.
The use of the controlled breathing pattern pro-
vided EBCwhich did not have a difference in pH from
the EBCproduced by spontaneous breathing.
Further examination of the controlled breathing
pattern with different frequencies and volumes within
a wider population with different lung sizes are needed
for further validation of decreased variability in the
EBC endpoints.
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